- Home
- SNTG vs BGLC Comparison
SNTG vs BGLC Comparison
Compare SNTG & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- BGLC
- Stock Information
- Founded
- SNTG 2009
- BGLC 2017
- Country
- SNTG China
- BGLC Malaysia
- Employees
- SNTG N/A
- BGLC N/A
- Industry
- SNTG Finance: Consumer Services
- BGLC Medical Specialities
- Sector
- SNTG Finance
- BGLC Health Care
- Exchange
- SNTG Nasdaq
- BGLC Nasdaq
- Market Cap
- SNTG 5.2M
- BGLC 5.8M
- IPO Year
- SNTG 2021
- BGLC N/A
- Fundamental
- Price
- SNTG $1.60
- BGLC $0.23
- Analyst Decision
- SNTG
- BGLC
- Analyst Count
- SNTG 0
- BGLC 0
- Target Price
- SNTG N/A
- BGLC N/A
- AVG Volume (30 Days)
- SNTG 14.0K
- BGLC 1.5M
- Earning Date
- SNTG 04-25-2025
- BGLC 05-14-2025
- Dividend Yield
- SNTG N/A
- BGLC N/A
- EPS Growth
- SNTG N/A
- BGLC N/A
- EPS
- SNTG N/A
- BGLC N/A
- Revenue
- SNTG $146,472.00
- BGLC $9,259,858.00
- Revenue This Year
- SNTG N/A
- BGLC N/A
- Revenue Next Year
- SNTG N/A
- BGLC N/A
- P/E Ratio
- SNTG N/A
- BGLC N/A
- Revenue Growth
- SNTG N/A
- BGLC N/A
- 52 Week Low
- SNTG $1.57
- BGLC $0.21
- 52 Week High
- SNTG $3.97
- BGLC $1.00
- Technical
- Relative Strength Index (RSI)
- SNTG 34.09
- BGLC 36.29
- Support Level
- SNTG $1.77
- BGLC $0.23
- Resistance Level
- SNTG $1.85
- BGLC $0.32
- Average True Range (ATR)
- SNTG 0.06
- BGLC 0.03
- MACD
- SNTG -0.02
- BGLC -0.00
- Stochastic Oscillator
- SNTG 8.57
- BGLC 9.15
Stock Price Comparison Chart: SNTG vs BGLC
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.